Boehringer Ingelheim India

Contact our representative:

Mukti Sahoo
+91 70081 75918
mukti.sahoo@boehringer-ingelheim.com

https://www.boehringer-ingelheim.in

facebook-icon twitter-icon youtube-icon

About Boehringer Ingelheim

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. We work together globally and with integrity. Our focus articulates who we are and what we strive for, how we work and what we want to achieve. As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.

In India, Boehringer  Ingelheim is one the fastest growing multinational pharmaceutical. It was set up in 2003 and currently ranks 8th among MNCs. Boehringer Ingelheim India operates through its business areas of Human Pharmaceuticals, Animal Health and Clinical operations.

We have a strategic alliance with Lupin Ltd for diabetes in India. This partnership shows our commitment towards addressing challenges in diabetes management by providing broader access to innovative medicine. Through its research and scientific excellence, Boehringer Ingelheim India will continue to introduce innovative products to address the unmet medical needs.

Our products

Trajenta

Linagliptin 5mg

Trajenta Duo

Linagliptin 2.5 mg + metformin HCI 500/850/1000mg

Glyxambi

Empagliflozin 10/25mg + linagliptin 5mg

Jardiance

Empagliflozin 10/25mg

Jardiance Met

Empagliflozin 5/12.5mg + metformin HCI 500/1000mg

Contact Boehringer